科华生物获得医疗器械注册证

Core Viewpoint - Kehua Bio has received a medical device registration certificate from the National Medical Products Administration for its Hepatitis A Virus IgM Antibody Test Kit, which is expected to positively impact the company's business development and enrich its product line [1]. Group 1 - The product is designed for the qualitative detection of Hepatitis A Virus IgM antibodies in human serum or plasma [1]. - The acquisition of the medical device registration certificate signifies a regulatory approval that enhances the company's product offerings [1]. - The introduction of this new product is anticipated to have a positive effect on the company's business growth [1].